In-Depth Stock Evaluation of Evolus
In-Depth Stock Evaluation of Evolus※ Evolus, Inc. (NASDAQ: EOLS) is a prominent player in the aesthetic healthcare industry, specializing in the development and commercialization of innovative medical aesthetic products. Best known for its flagship product, Jeuveau®, a botulinum toxin type A injection, Evolus aims to carve out a significant share in the fast-growing global aesthetics market. Giv..
TIPs/주식
2024. 8. 22. 21:12